AU647737B2
(en)
*
|
1989-03-24 |
1994-03-31 |
Regents Of The University Of California, The |
Endothelial cell growth factor, isolation and expression
|
US5332671A
(en)
*
|
1989-05-12 |
1994-07-26 |
Genetech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
US7300791B2
(en)
*
|
1989-05-12 |
2007-11-27 |
Genentech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
US20030114374A1
(en)
*
|
1989-05-12 |
2003-06-19 |
Genentech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
DE69024261T2
(de)
*
|
1989-05-24 |
1996-07-18 |
Merck & Co Inc |
Reinigung und Charakterisierung eines von einem Glioma abstammenden Wachstumsfaktors
|
US5219739A
(en)
*
|
1989-07-27 |
1993-06-15 |
Scios Nova Inc. |
DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
|
US5194596A
(en)
*
|
1989-07-27 |
1993-03-16 |
California Biotechnology Inc. |
Production of vascular endothelial cell growth factor
|
EP0506477B1
(de)
|
1991-03-28 |
1999-06-23 |
Merck & Co. Inc. |
Untereinheit-C des vaskulären endothelialen Zellwachstumsfaktors
|
US6582959B2
(en)
|
1991-03-29 |
2003-06-24 |
Genentech, Inc. |
Antibodies to vascular endothelial cell growth factor
|
JP3172841B2
(ja)
*
|
1992-02-19 |
2001-06-04 |
株式会社日立製作所 |
薄膜トランジスタとその製造方法及び液晶表示装置
|
US5932540A
(en)
|
1994-03-08 |
1999-08-03 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US7153827B1
(en)
*
|
1994-03-08 |
2006-12-26 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 and methods of use
|
US7186688B1
(en)
|
1994-03-08 |
2007-03-06 |
Human Genome Sciences, Inc. |
Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
|
US7109308B1
(en)
*
|
1994-03-08 |
2006-09-19 |
Human Genome Sciences, Inc. |
Antibodies to human vascular endothelial growth factor 2
|
US6040157A
(en)
*
|
1994-03-08 |
2000-03-21 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US6608182B1
(en)
*
|
1994-03-08 |
2003-08-19 |
Human Genome Sciences, Inc. |
Human vascular endothelial growth factor 2
|
JPH09510093A
(ja)
|
1994-03-08 |
1997-10-14 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
血管内皮細胞増殖因子2
|
US6734285B2
(en)
|
1994-03-08 |
2004-05-11 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 proteins and compositions
|
US5928939A
(en)
*
|
1995-03-01 |
1999-07-27 |
Ludwig Institute For Cancer Research |
Vascular endothelial growth factor-b and dna coding therefor
|
US6100071A
(en)
|
1996-05-07 |
2000-08-08 |
Genentech, Inc. |
Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
|
US6013780A
(en)
*
|
1996-09-06 |
2000-01-11 |
Technion Research & Development Co. Ltd. |
VEGF145 expression vectors
|
ATE343400T1
(de)
|
1996-09-24 |
2006-11-15 |
Merck & Co Inc |
Verbindungen zur hemmung der angiogenese durch gentherapie
|
US6750044B1
(en)
|
1996-10-17 |
2004-06-15 |
Genentech, Inc. |
Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
|
US20030165467A1
(en)
*
|
1997-01-21 |
2003-09-04 |
Technion Research & Development Co., Ltd. |
Angiogenic factor and use thereof in treating cardiovascular disease
|
JP2001509168A
(ja)
*
|
1997-01-29 |
2001-07-10 |
コーネル リサーチ ファウンデーション、インコーポレイティッド |
血管新生を誘導するためのアデノウイルスベクターの多部位送達
|
DE69838334T2
(de)
|
1997-06-18 |
2008-06-12 |
Merck & Co., Inc. (A New Jersey Corp.) |
Kdr, ein menschlicher tyrosin kinase rezeptor
|
US20030082540A1
(en)
*
|
1997-09-17 |
2003-05-01 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO1999018792A1
(en)
*
|
1997-10-10 |
1999-04-22 |
Johns Hopkins University |
Gene delivery compositions and methods
|
US6391311B1
(en)
|
1998-03-17 |
2002-05-21 |
Genentech, Inc. |
Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
|
CN1295617A
(zh)
|
1998-02-06 |
2001-05-16 |
科莱特诺医疗公司 |
血管生成因子-血管内皮细胞生长因子vegf的突变体
|
US6676937B1
(en)
*
|
1998-03-09 |
2004-01-13 |
Caritas St. Elizabeth's Medical Center Of Boston Inc. |
Compositions and methods for modulating vascularization
|
US20040228834A1
(en)
*
|
1998-03-09 |
2004-11-18 |
Jeffrey Isner |
Compositions and methods for modulating vascularization
|
DK2016951T3
(da)
|
1998-03-17 |
2012-09-24 |
Genentech Inc |
VEGF- og BMP1-homologe polypeptider
|
US7344880B2
(en)
*
|
1998-04-24 |
2008-03-18 |
Genentech, Inc. |
Nucleic acid encoding PRO9912 polypeptides
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
JP2002532382A
(ja)
|
1998-09-09 |
2002-10-02 |
サイオス インコーポレイテッド |
高血圧を処置する方法およびそこでの使用のための組成物
|
US7030083B2
(en)
*
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
ATE300957T1
(de)
|
1998-12-22 |
2005-08-15 |
Genentech Inc |
Antagonisten von vaskular-endothelialen zellwachstumsfaktoren und ihre anwendung
|
US7223724B1
(en)
|
1999-02-08 |
2007-05-29 |
Human Genome Sciences, Inc. |
Use of vascular endothelial growth factor to treat photoreceptor cells
|
US6783954B2
(en)
*
|
1999-03-05 |
2004-08-31 |
Compugen Ltd. |
VEGF nucleic acid and amino acid sequences
|
US6887468B1
(en)
|
1999-04-28 |
2005-05-03 |
Board Of Regents, The University Of Texas System |
Antibody kits for selectively inhibiting VEGF
|
US6703020B1
(en)
|
1999-04-28 |
2004-03-09 |
Board Of Regents, The University Of Texas System |
Antibody conjugate methods for selectively inhibiting VEGF
|
CA2374050A1
(en)
*
|
1999-05-20 |
2000-11-30 |
Scios Inc. |
Vascular endothelial growth factor dimers
|
US6475796B1
(en)
|
1999-05-20 |
2002-11-05 |
Scios, Inc. |
Vascular endothelial growth factor variants
|
US7307153B2
(en)
*
|
1999-12-23 |
2007-12-11 |
Genentech, Inc. |
Antibodies that bind PRO9912
|
US7164001B2
(en)
*
|
2000-01-20 |
2007-01-16 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
EP2792747A1
(de)
|
2000-06-23 |
2014-10-22 |
Genentech, Inc. |
Zusammensetzungen und Verfahren zur Diagnose und Behandlung von Erkrankungen in Verbindung mit Angiogenese
|
CA2648048A1
(en)
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
CA2386103A1
(en)
*
|
2000-08-04 |
2002-02-14 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US7067317B2
(en)
*
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
WO2002046412A2
(en)
*
|
2000-12-07 |
2002-06-13 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
JP2004536579A
(ja)
*
|
2001-04-13 |
2004-12-09 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
血管内皮増殖因子2
|
US20050232921A1
(en)
*
|
2001-04-13 |
2005-10-20 |
Rosen Craig A |
Vascular endothelial growth factor 2
|
EP1385862A4
(de)
*
|
2001-04-13 |
2005-03-02 |
Human Genome Sciences Inc |
Vaskulärer endothelwachstumsfaktor 2
|
US7402312B2
(en)
*
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
WO2002083850A2
(en)
*
|
2001-04-13 |
2002-10-24 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
KR101008734B1
(ko)
*
|
2001-08-29 |
2011-01-14 |
제넨테크, 인크. |
유사분열촉진 활성을 가진 Bv8 핵산 및 폴리펩티드
|
US7435419B2
(en)
*
|
2002-07-19 |
2008-10-14 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating pre-eclampsia or eclampsia
|
CA2496253C
(en)
|
2002-07-19 |
2016-05-10 |
Beth Israel Deaconess Medical Center, Inc. |
Methods of diagnosing and treating pre-eclampsia or eclampsia
|
US7335362B2
(en)
*
|
2002-07-19 |
2008-02-26 |
Beth Israel Deaconess Medical Center |
Methods of treating pre-eclampsia or eclampsia
|
WO2004070004A2
(en)
*
|
2003-01-29 |
2004-08-19 |
Merck & Co., Inc. |
Rat receptor tyrosine kinase, kdr
|
KR101118340B1
(ko)
*
|
2003-03-12 |
2012-04-12 |
제넨테크, 인크. |
조혈을 촉진하기 위한 bv8 및(또는) eg-vegf의용도
|
WO2005069906A2
(en)
*
|
2004-01-16 |
2005-08-04 |
Yale University |
Methods and compositions relating to vascular endothelial growth factor and th2 mediated inflammatory diseases
|
WO2005084329A2
(en)
*
|
2004-03-02 |
2005-09-15 |
Ludwig Institute For Cancer Research |
Method for inhibiting tumor formation and growth
|
JP2007536251A
(ja)
*
|
2004-05-04 |
2007-12-13 |
チルドレンズ メディカル センター コーポレーション |
子癇前症の処置のための方法および組成物
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
JP2008513356A
(ja)
*
|
2004-08-09 |
2008-05-01 |
アリオス バイオファーマ インク. |
合成高度糖鎖付加プロテアーゼ耐性ポリペプチド変異体、それを使用する経口製剤および方法
|
AR050608A1
(es)
*
|
2004-08-19 |
2006-11-08 |
Alza Corp |
Aparato y metodo para administracion transdermica de factores de crecimiento endotelial vascular
|
DK1804836T3
(da)
|
2004-09-24 |
2011-01-24 |
Beth Israel Hospital |
Fremgangsmåder til diagnosticering og behandling af graviditetskomplikationer
|
US7740849B2
(en)
*
|
2004-09-24 |
2010-06-22 |
Beth Israel Deaconess Medical Center |
Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
|
DE602005023216D1
(de)
*
|
2004-12-15 |
2010-10-07 |
Beth Israel Hospital |
Nukleinsäuren und polypeptide zur diagnose und behandlung von schwangerschaftskomplikationen
|
WO2006094106A2
(en)
|
2005-02-28 |
2006-09-08 |
Sangamo Biosciences, Inc. |
Anti-angiogenic methods and compositions
|
US7893244B2
(en)
*
|
2005-04-12 |
2011-02-22 |
Intradigm Corporation |
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
|
WO2006110813A2
(en)
*
|
2005-04-12 |
2006-10-19 |
Intradigm Corporation |
Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases
|
MX2007015943A
(es)
*
|
2005-06-17 |
2008-03-07 |
Genentech Inc |
Curacion de heridas.
|
US8329175B2
(en)
*
|
2005-08-26 |
2012-12-11 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders
|
US20090286271A1
(en)
*
|
2006-05-31 |
2009-11-19 |
Karumanchi Ananth S |
Methods of Diagnosing and Treating Complications of Pregnancy
|
US20110172293A1
(en)
|
2008-07-08 |
2011-07-14 |
Fish Jason E |
Methods and Compositions for Modulating Angiogenesis
|
CA2799227C
(en)
|
2010-05-14 |
2020-06-16 |
Beth Israel Deaconess Medical Center, Inc. |
Extracorporeal devices and methods of treating complications of pregnancy
|
EP3277815B1
(de)
|
2015-04-03 |
2021-09-22 |
University of Massachusetts |
Oligonukleotidverbindungen zur behandlung von präeklampsie und anderen angiogenen erkrankungen
|
EP3408391A4
(de)
|
2016-01-31 |
2019-08-28 |
University of Massachusetts |
Verzweigte oligonukleotide
|
US11753638B2
(en)
|
2016-08-12 |
2023-09-12 |
University Of Massachusetts |
Conjugated oligonucleotides
|
KR20210093227A
(ko)
|
2018-08-10 |
2021-07-27 |
유니버시티 오브 매사추세츠 |
Snp를 표적화하는 변형된 올리고뉴클레오티드
|
TW202315943A
(zh)
|
2021-06-23 |
2023-04-16 |
麻薩諸塞大學 |
用於治療子癇前症及其它血管新生病症的最佳化抗flt1寡核苷酸化合物
|